Riskpilot← Back to searchSign inGet full accessHERREKLINIKKEN SKANDINAVIA AS
ASActiveOrg 921548621Stranden 87, 0250 OsloOther human health activities n.e.c. · NACE 8699Est. 20180 employees
Revenue 2024
NOK 560K
-19% vs 2023
EBITDA margin
-19.9%
-12% vs 2023
Equity ratio
6.4%
Financial strength
Net profit 2024
NOK -144K
-9% vs 2023
| Revenue | NOK 560K | -19% |
| EBITDA | NOK -112K | -12% |
| Net profit | NOK -144K | -9% |
| Total assets | NOK 628K | -2% |
| Equity | NOK 40K | -78% |
| Employees | 0 | — |
Legal name
HERREKLINIKKEN SKANDINAVIA AS
Org number
921548621
Legal form
Aksjeselskap
NACE code
8699 · Other human health activities n.e.c.
Founded
12. oktober 2018
Share capital
NOK 30 000
Employees
0
VAT registered
No
Audit selected
No
Last report
2024-12-31
Financial year
January – December
Signatory rights
Daglig leder og styrets leder i fellesskap.
Company purpose
Alt av medisinske tjenester, livsstil og velvære.
Address
Stranden 87, 0250 Oslo
Risika for professionals
Risika provides regulated workflow tools for finance, procurement and compliance teams that need monitoring, alerts and an API.
| Item | 2020 | 2021 | 2022 | 2023 | 2024 |
|---|---|---|---|---|---|
| Revenue | 165 | 1 101 | 1 032 | 692 | 560 |
| Staff expenses | −0 | −0 | −0 | −0 | −0 |
| EBITDA | 17 | 365 | 84 | −99 | −112 |
| Depreciation & amort. | −0 | −0 | −32 | −32 | −32 |
| EBIT | 17 | 365 | 52 | −132 | −144 |
| Net financials | −0 | −0 | −0 | −0 | 0 |
| Profit before tax | 17 | 365 | 51 | −132 | −144 |
| Tax | 4 | 80 | 11 | −0 | −0 |
| Net profit | 13 | 285 | 40 | −132 | −144 |
| Item | 2020 | 2021 | 2022 | 2023 | 2024 |
|---|---|---|---|---|---|
| Total assets | 370 | 729 | 682 | 641 | 628 |
| Equity | 31 | 316 | 316 | 184 | 40 |
| Long-term debt | 0 | 0 | 0 | 0 | 0 |
| Short-term debt | 340 | 413 | 367 | 457 | 588 |
| Total debt | 340 | 413 | 367 | 457 | 588 |
EBITDA margin
-19.9%
This company
15.8%
Market median
-226% vs market
20202024
Equity ratio
6.4%
This company
38.2%
Market median
-83% vs market
20202024
Return on equity
-360.8%
This company
18.4%
Market median
-2061% vs market
20202024
Net profit margin
-25.7%
This company
8.1%
Market median
-417% vs market
20202024
Asset turnover
0.89×
This company
1.12×
Market median
+21% vs market
20202024
Debt / equity
14.75×
This company
0.62×
Market median
-2279% vs market
20202024
- Annual report 2024Filed via Brønnøysundsregistrene · Period 2024-01-01 – 2024-12-31
- Annual report 2023Filed via Brønnøysundsregistrene · Period 2023-01-01 – 2023-12-31
- Annual report 2022Filed via Brønnøysundsregistrene · Period 2022-01-01 – 2022-12-31
- Annual report 2021Filed via Brønnøysundsregistrene · Period 2021-01-01 – 2021-12-31
- Annual report 2020Filed via Brønnøysundsregistrene · Period 2020-01-01 – 2020-12-31
| Name | Role | Member since |
|---|---|---|
| Current (1) | ||
SS Chief Executive Officer | Chief Executive Officer | 2020 |
| Former (1) | ||
EE Deputy Member | Deputy Member | 2021 – 2022 |
| Name | Role | Member since |
|---|---|---|
| Current (3) | ||
| Board of Directors | 2022 | |
| Chairman | 2022 | |
| Board of Directors | 2022 | |
| Former (1) | ||
| Deputy Chairman | 2021 – 2022 | |
| Shareholder | Type | Ownership | Votes | Since |
|---|---|---|---|---|
| Company | 100% | 100% | 2022 |
Beneficial ownership (UBO) data access is restricted in Denmark as of September 2025 per the EU 6th AML Directive. Learn more.
Skandinavia Invest As
HERREKLINIKKEN SKANDINAVIA AS Board members of HERREKLINIKKEN SKANDINAVIA AS also hold positions in 0 other companies.
| Person | Role here | Other companies |
|---|---|---|
| Svein Sande | Chief Executive Officer | 0 companies |
| Erik Edelmann | Deputy Member | 0 companies |
| Lars Løyning | Board of Directors | 0 companies |
| Arve Lund | Chairman | 0 companies |
| Sissel Elisabeth Fredheim | Board of Directors | 0 companies |
| Bente Irene Fredheim | Deputy Chairman | 0 companies |